Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 9M | 14M |
| Cost of revenue | 9M | 15M |
| Gross profit | −300,039 | −964,617 |
| Research and development | 244,237 | 162,152 |
| Selling, general and administrative | 9M | 11M |
| Operating expenses | 10M | 12M |
| Operating income | −10M | −13M |
| Pre-tax income | 5M | −13M |
| Net income | 5M | −13M |
| Earnings per share | 1.52 | −47.93 |
| Earnings per share, diluted | 0.33 | −47.93 |
| Weighted average shares | 3M | 279,201 |
| Weighted average shares, diluted | 14M | 279,201 |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 31 Oct 2024 | 30 Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 13M | 2M | 3M | 8M | 12M | 6M | — | 311,883 |
| Receivables | 318,505 | 97,331 | 194,948 | 112,079 | 398,873 | 132,230 | — | 167,701 |
| Current assets | 14M | 2M | 7M | 9M | 13M | 6M | — | 1M |
| Property, plant and equipment | 1,868 | 2,505 | 3,143 | 3,780 | 4,417 | 5,055 | — | 5,692 |
| Total assets | 39M | 26M | 13M | 14M | 18M | 11M | — | 3M |
| Current liabilities | 3M | 4M | 4M | 3M | 4M | 4M | — | 7M |
| Total liabilities | — | 4M | 4M | 3M | 5M | 4M | — | 8M |
| Equity | 36M | 22M | 9M | 11M | 14M | 7M | — | −5M |
| Shares outstanding | 639,738 | 6M | 4M | 3M | 2M | 2M | 225 | 148,836 |
| Shares issued | 639,738 | 6M | 4M | 3M | 2M | 2M | 225 | 148,836 |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | −8M | −8M |
| Depreciation and amortisation | 2,550 | 2,557 |
| Share-based compensation | 2M | 4M |
| Capital expenditure | — | 12,922 |
| Investing cash flow | −5M | −2M |
| Financing cash flow | 9M | 14M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator